All analyses
AI analysis

Galle Face Capital Partners PLC: research report

UndervaluedbullishNov 6, 2026

Evidence points bullish because shares trade below book and the rights issue raises LKR 2.0 billion for borrowings and investments. The catch is June profit fell 72.2%.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • The shares trade at 0.74 times book value, or 74 cents for each rupee of net assets.
  • The confirmed rights issue raises LKR 2.0 billion to settle short-term borrowings and fund investments.
  • The company scores 97 of 100 on price against book value, earnings and dividends across the CSE.

Against this. June-quarter net profit fell 72.2% year-on-year to LKR 83.5 million, showing how volatile portfolio-led earnings can be.

Operating margin
93.1%
of revenue plus other operating income, which is larger than revenue here
Net margin
81.0%
of revenue plus other operating income; profit here is mostly not from revenue
Return on equity
30.6%sector 13.0%
full year to Mar 31, 2026
P/E
2.6sector 7.1
earnings Rs 7.29 per share, year to Mar 2026
P/B
0.80sector 0.97
book Rs 23.74 per share
Dividend yield
3.56%sector 0.75%
9.3% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 6, 2026. Sector figures are the median of 54 listed companies in the same sector.

Overview

Galle Face Capital Partners is an investment company whose value rests on a portfolio of Sri Lankan listed shares, including banking, consumer, hospitality, tobacco and healthcare holdings. The latest June quarter remained profitable, but its investment-led earnings were markedly lower than the comparable quarter a year earlier.

The defining current change is the confirmed rights issue, which will bring fresh capital for short-term borrowings and future investments while materially changing the number of shares entitled to the portfolio.

Price performance

At LKR 17.60 on 6 November 2026, the share was down 12.2% over three months against a 0.6% decline in the ASPI, and down 34.9% over one year against a 6.8% index fall. The share therefore lagged the market substantially over both windows.

The adjusted price sat 15.8% up from its 52-week low and 46.3% below its high. History records five falls of 15% or more in three years, the deepest 55%, which has not yet recovered. Trading is thin: median daily turnover was LKR 379,000, and a LKR 1 million order is more than everything that trades on a typical day, 264% of it.

Returns are restated onto today's share basis. The March 1:4 split and the confirmed 1:1 rights issue mean the adjusted return record differs from the screen-price history because of corporate actions, not trading performance alone.

Valuation

At 2.4 times P/E, the market price represents 2.4 rupees for every rupee of trailing profit, versus a 7.01 times median for 53 banks and finance peers. Its P/E is the lowest among the 48 peers with usable earnings multiples, although investment portfolio gains can make a low multiple volatile rather than automatically durable.

The 0.74 times P/B means the market price is 74 cents for each rupee of net assets, below the sector median of 0.95 times. It is also cheaper than 74% of days since January 2019, so the discount is not just relative to peers but also below much of the company's own recorded valuation history. The company scores 97 of 100 on price against book value, earnings and dividends across the CSE, placing it in the Undervalued band.

The 3.8% dividend yield is above the 3.4% sector median, while dividends per share rose from LKR 0.451 in FY2024 to LKR 0.677 in FY2026. A buyer at the current price is relying on a trailing P/E that includes variable portfolio income: the latest quarter supplied 12.9% of trailing EPS, and the same price would equal 1.4 times earnings if that quarter had matched its year-ago net margin.

News and sentiment

Company coverage was normal rather than unusually active, with one article in the past 30 days against a monthly baseline of 1.3. Across 90 days, nine material items comprised three positive and six neutral articles, largely focused on dividends and the rights issue.

The rights issue dates were reported on 6 November 2026. The confirmed terms are one new share for each existing share at LKR 16, with an ex-date of 23 November; reported proceeds are LKR 2.0 billion and the stated use is settling short-term bank and intercompany borrowings and financing investments. The issue is stated to double ordinary shares, so future per-share claims will be spread across a much larger share base.

Financials

June-quarter revenue rose 76.2% year-on-year to LKR 74.6 million, yet operating profit fell 70.7% to LKR 88.0 million and net profit fell 72.2% to LKR 83.5 million. For an investment company, this divergence shows that the profit available to shareholders moved mainly with portfolio and other investment income rather than with the revenue line alone.

Gross profit is not provided, so no gross margin can be assessed. Operating margin was 118.1% versus 709.2% a year earlier, while net margin was 112.0% versus 710.1%; margins above revenue reflect gains and income outside ordinary revenue. Against prior June quarters, operating margin ranked 5th of 8 and net margin 4th of 8, making the latest print middling rather than an extreme in its comparable June record. Below-the-line items reduced June operating profit by LKR 4.5 million, versus a small benefit a year earlier.

Equity was LKR 2.9 billion at June, up from LKR 2.3 billion a year earlier. The filing used 118.3 million shares, compared with 28.9 million a year earlier because the March 1:4 split mechanically multiplied the count; EPS across those dates should not be read as a like-for-like per-share trend. The next figures due cover the September quarter, so the June results remain the latest filed operating record.

Risks

The leading risk is portfolio-income volatility. June net profit was LKR 83.5 million, down LKR 217.0 million year-on-year, despite revenue growth, demonstrating that reported earnings can move sharply with changes in investment and other income.

Funding is the next material issue. At the March year-end, liabilities were 0.09 times equity, down from 0.12 times a year earlier, but the planned LKR 2.0 billion rights issue is specifically intended to settle short-term bank and intercompany borrowings. Its use of proceeds therefore matters as much as the fresh cash raised.

The share's trading record and liquidity add practical risk: the deepest drawdown in the last three years reached 55% and remains unrecovered, while normal turnover is below LKR 0.4 million a day. The wider banks and finance backdrop also includes a rupee depreciation of 6.8% year to end-October, which is relevant to the environment in which several portfolio holdings operate but is not company-specific news.

Outlook

As at 6 November 2026, the next filed catalyst is the September interim quarter, which is due now based on the exchange's usual reporting window of 2 to 14 November. It will show whether the sharp June profit decline persisted after the latest filed period.

The other confirmed event is the 23 November rights ex-date. The issue will add capital for borrowings and investments but double the ordinary share base, making subsequent portfolio returns and capital deployment more important to each share's claim on net assets and earnings. The available data cannot show how the new funds will ultimately be invested or the returns those investments will generate.

About this report. Generated on Nov 6, 2026 from market data up to Nov 6, 2026, 9 material news articles over 90 days and financials to Jun 30, 2026, and scored 97 of 100 on value (undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports